Results
|
|
1381.
|
|
|
|
1382.
|
|
|
|
1383.
|
|
|
|
1384.
|
|
|
|
1385.
|
|
|
|
1386.
|
|
|
|
1387.
|
|
|
|
1388.
|
|
|
|
1389.
|
|
|
|
1390.
|
A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction. [electronic resource] by
- Said, S
- Omar, K
- Koetsawang, S
- Kiriwat, O
- Srisatayapan, Y
- Kazi, A
- Ajmal, F
- Wynter, H H
- Pretnar-Darovec, A
- Benitez, I B
Producer: 19870210
In:
Contraception vol. 34
Availability: No items available.
|
|
|
1391.
|
|
|
|
1392.
|
|
|
|
1393.
|
|
|
|
1394.
|
|
|
|
1395.
|
|
|
|
1396.
|
|
|
|
1397.
|
|
|
|
1398.
|
|
|
|
1399.
|
|
|
|
1400.
|
|